The first QC product to provide the Harding Test for photosensitive epilepsy (PSE) within HDR content is now available.
PSE is triggered by visual stimuli (such as light flashes, stroboscopic effects or flash photography) that overload the brain temporarily and cause a seizure. PSE affects about one in 4,000 people.
Cambridge Research Systems provides the most accurate and widely used implementation as part of its HardingFPA Test for detection of such visual patterns.
The new HardingFPA algorithm for HDR has been implemented in the latest release of Venera’s AQC product Pulsar (7.0).
Broadcasters, studios and post houses can now perform PSE risk analysis of HDR-10 and Dolby Vision content and receive a HardingFPA compliance certificate.
Fereidoon Khosravi, Chief Business Development Officer at Venera, said: “For many years, the HardingFPA PSE risk analysis has been the worldwide de facto standard for PSE detection for SDR content. Media companies dealing with HDR content have been eagerly anticipating a means to accurately validate their HDR content. We are pleased to be the first to offer the latest enhancements for PSE detection in HDR content.
Steve Elliott, MD of Cambridge Research System, added: “We appreciate our long-term partnership with Venera Technologies and are pleased to have them be the first OEM implementation of our HardingFPA PSE risk analysis of HDR content.”
Stand Number: 7.D25
Company: Venera Technologies